Hikma Pharmaceuticals PLC
LSE:HIK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
UK |
|
Mr DIY Group (M) Bhd
OTC:MDIYF
|
MY |
|
B
|
Bollore SE
XMUN:BOP
|
FR |
|
Heineken NV
AEX:HEIA
|
NL |
|
L
|
L'Oreal SA
OTC:LRLCY
|
FR |
|
A
|
AXA SA
BMV:AXAN
|
FR |
|
IHI Corp
TSE:7013
|
JP |
|
A
|
Alphabet Inc
XETRA:ABEC
|
US |
|
LG Electronics Inc
KRX:066570
|
KR |
|
Huntington Ingalls Industries Inc
NYSE:HII
|
US |
|
O
|
Orlen SA
PSE:PKN
|
PL |
|
Brambles Ltd
ASX:BXB
|
AU |
|
C
|
Coles Group Ltd
F:2OF
|
AU |
|
Centerspace
NYSE:CSR
|
US |
|
V
|
Vornado Realty Trust
LSE:0LR2
|
US |
|
C
|
Carrefour SA
F:CAR
|
FR |
|
Hoya Corp
OTC:HOCPF
|
JP |
|
C
|
Cerence Inc
F:0S6
|
US |
|
Z
|
Zijin Mining Group Co Ltd
DUS:FJZ
|
CN |
|
BYD Co Ltd
OTC:BYDDY
|
CN |
|
I
|
Industrie De Nora SpA
F:M3D
|
IT |
|
Devon Energy Corp
NYSE:DVN
|
US |
|
STERIS plc
F:2TG
|
IE |
|
Lynas Rare Earths Ltd
ASX:LYC
|
MY |
Bankruptcy Probability
Hikma Pharmaceuticals PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hikma Pharmaceuticals PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
3.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
362.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
354B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
218.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
194.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
288.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hikma Pharmaceuticals PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hikma Pharmaceuticals PLC has total debt of 1.5B USD. This includes both short-term (0 USD) and long-term (1.5B USD) debt.
You can find a full breakdown on its Balance Sheet.